The Valley Desk

NCT00735371 · Interventional trial

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Overall registry status Completed

Phase 3

Conditions Attention Deficit Hyperactivity Disorder (ADHD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov